An interventional study of Cognitive job accommodation in Stroke, Ischemic, Cognitive Impairment and Fatigability Post Stroke, sponsored by Finnish Institute of Occupational Health. Recruiting at 1 site in Finland. Open to participants aged 18 Years to 68 Years. Per ClinicalTrials.gov, last updated 2025-03-13.
Sponsored by Finnish Institute of Occupational Health · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 38 studies in Ischemic Stroke with a site in Finland — 6 open to participants now, 10 under way, 1 of them phase 3. Ischemic Stroke · Finland.
Among the 38 studies in Ischemic Stroke with a site in Finland, this one is the 26th largest by planned enrollment of the 30 interventional ones that give a count, is one of 2 that started in 2025, is one of 8 with no phase, and was the 37th registered.
2,629 studies on the registry are indexed under Ischemic Stroke; 983 are open to participants now.
Browse Ischemic Stroke studies →6 of the 38 studies in Ischemic Stroke with a site in Finland are open now. Recruiting first, the newest first:
Karolinska Institutet · Sites in Finland, Sweden
Ages 18+
Insel Gruppe AG, University Hospital Bern · Sites in Finland, Austria, Belgium and 9 more countries
Ages 18+
University Hospital, Basel, Switzerland · Sites in Finland, United States, Argentina and 6 more countries
Ages 18+ · Women only
Jukka Putaala · Sites in Finland
Ages 40+
Medtronic Neurovascular Clinical Affairs · Sites in Finland, Argentina, Australia and 21 more countries
Ages 18+
A study can be open while its sites in Finland have not opened yet or have stopped. Only those recruiting at a site in Finland →
Of the 668 Ischemic Stroke studies recruiting now, 403 (60%) set no upper age limit and 62 (9%) stop at 75 or younger; 27 take children under 18; 41 take healthy volunteers.
This study: 18 Years to 68 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
38 studies; the count open now beside each. This study's row is marked.
First in 2000; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is below the median of 120 across 1,788 interventional studies indexed under Ischemic Stroke.
Median enrollment 495 across the 30 interventional studies, 1,200 across the 8 observational. Of the 24 that completed or were terminated, 9 (38%) have results posted.
This tab as a report to print or save as PDF → With an account.
17 of 38 have an industry lead sponsor. The 10 most frequent:
Finnish Institute of Occupational Health is the lead sponsor of 13 studies on the registry; 2 are open to participants now.
Finnish Institute of Occupational Health has 1 study filed under Ischemic Stroke — fewer than ten, so there is no comparison to draw.
1 of the studies in Ischemic Stroke with a site in Finland that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06709898Finnish Institute of Occupational HealthStroke in Working Age and Job Accommodation in Facilitating Transition Back to Work | 2026-12-31 |
Add it to your calendar (.ics) → With an account.
Among the 38 studies in Ischemic Stroke with a site in Finland, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The aim of this randomized controlled trial (RCT) is to investigate whether cognitive job accommodation intervention enhances return to work, work ability and performance after ischemic stroke in working-age population. The main questions are:
Researchers will compare the intervention group to a control group returning to work after stroke with current healthcare practices and work procedures.
Participants:
Introduction: Strokes are one of the most significant conditions affecting cognition among working-age adults. Incidence of stroke increases in older age and due to the lengthening of working careers, more people are experiencing strokes while still employed. Additionally, the incidence of strokes among younger workers has increased over recent decades. In Finland, 2000 - 3000 work-aged persons suffer a stroke annually. The majority experiences cognitive or emotional symptoms post-stroke, and for about half of them, these symptoms become long-lasting or permanent. The cognitive demands of modern work have steadily increased, and the severity of cognitive symptoms has been shown to strongly predict the likelihood of returning to work after a stroke. While job accommodation has been shown to be an effective way to support return to work after many illnesses, there is limited research on its benefits following a stroke. Furthermore, there is lack of research on cognitive job accommodation, despite health professionals finding it particularly challenging.
Aims: To evaluate the effect of job accommodations after stroke on various work and health related outcomes. In addition, information about working-aged stroke patients returning to work and the practices of job accommodation is provided. In the future these results can potentially be applied also to other conditions affecting cognition.
Participants and methods: This study will recruit 18-68 year old stroke patients who are returning to work (n ≈ 100). Participants will be randomized into either a job accommodation intervention group or a control group. The study will assess the benefits of cognitive job accommodation in terms of absenteeism, presenteeism, work modifications, perceived work ability, health indicators and cognitive and emotional symptoms. Participants will be followed through web-based surveys and novel cognitive tests over a 12-month period. The study will adopt a multidisciplinary approach (ergonomics, occupational psychology, neuropsychology, and medicine) and will be based on the International Classification of Functioning, Disability, and Health (ICF) model. Cognitive job accommodation will utilize an established model, a design form, and an instructional video.
Collaborators and target organizations: The research will be conducted in collaboration with the Helsinki University Hospital Neurocenter and the Finnish Institute of Occupational Health. In addition to these organizations the study is funded by the Finnish Work Environment Fund. The target organizations include occupational health services and workplaces of stroke survivors.
Utilization of Results: The methods developed in this study can be used in future collaborations between workplaces, occupational health services, and specialized healthcare. The findings can also be applied to other conditions that cause cognitive difficulties and require job accommodation.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
* In intervention neuropsychological information will be individually processed and transferred systematically from the neurological unit to occupational health service (OHS) to help design the individually tailored work modifications. * Information of the job accommodation will be given to employers. * Cognitive job accommodation is carried out at the workplace in cooperation between the employer, employee and OHS. * Feedback of the cognitively challenging work traits will be given to participants after returning to work.
Other: Cognitive job accommodation
Employees return to work according to standard health care and workplace procedures.
Job accommodation focused on the cognitive aspects at work
Absenteeism and presenteeism
Absenteeism and presenteeism are evaluated with World Health Organization's Health and Work Performance Questionnaire (HPQ) using both absolute and relative measures. Absolute absenteeism: hours in 4 week (higher value indicates worse outcome). Absolute presenteeism: single question measure of own job performance (score 0-10) analyzed according to the HPQ instructions (higher value indicates better outcome). Relative absenteeism: working hours in 4 week / expected working hours in 4 week. Relative presenteeism: evaluation of own job performance (score 0-10) / evaluation of most other workers job performance (score 0-10). This score is restricted to the range of 0.25 to 2.0 according to HPQ instructions. In both relative scores higher values indicate better outcome.
Time frame: 6 and 12 months
Work ability
Estimate of the current work ability measured with single question (score range 0-10, higher score indicate better outcome) from Work Ability Index. Estimate of future work ability measured with single question (categorical variable: yes, no, maybe) from Work Ability Index.
Time frame: 6 and 12 months
Perceived success in returning to work
Subjectively evaluated success in returning to work. Single item question with 5 point Likert scale (5= very good; 1= very bad).
Time frame: 6 and 12 months
Cognitive demands of work and related difficulties
Frequency of different cognitive demands at work and related perceived difficulties measured with Brain Work Questionnaire. Frequency values are reported as averaged occurrence/week (lower values indicate better outcome), and related difficulties in ordinal response variable (0=no difficulties, 1=sometimes difficult, 2=often difficult). Higher value indicates worse outcome.
Time frame: 3 and 12 months
Cognitive symptoms at work
Cognitive symptoms at work measured with The Cognitive Function at Work Questionnaire total score (score range 0-58: higher value indicates worse outcome)
Time frame: 6 and 12 months
Stress
Estimates of perceived stress. General stress measured with single item stress question (score range 1-5, lower value indicates better outcome). Theme specific stress (at home, work and financial). Ordinal 4 point response scales. Questions from INTERSTROKE study.
Time frame: 6 and 12 months
Sick leave days
Number of days on sick leave after returning to work. Higher value indicates worse outcome.
Time frame: 6 and 12 months
Insomnia symptoms
Frequency of insomnia symptoms measured with single item question with ordinal 5 point scale (5=Every night or nearly every night; 1=never). Higher value indicates worse outcome.
Time frame: 6 and 12 months
Fatigue symptoms
Fatigue symptoms measured with Fatigue Assessment Scale (FAS). Total score range 10-50. Higher score indicates worse outcome.
Time frame: 6 and 12 months
Stroke related life satisfaction
Perceived life satisfaction based on the Young Stroke Questionnaire (total score 0-100; where higher score indicates better outcome)
Time frame: 6 and 12 months
Mental job strain
Perceived mental job strain. Single item question with ordinal 1-5 point response scale (1=not at all; 5 very much). Higher value indicates worse outcome.
Time frame: 6 and 12 months
Perceived cognitive and emotional difficulties in general
Perceived cognitive and emotional difficulties in general measured with Check List for Cognitive and Emotional Consequences. Likert scale questions 0-2. Higher values indicate worse outcome.
Time frame: 6 and 12 months
Modified Rankin scale
The Modified Rankin Scale (mRS) measures degree of disability/dependence after a stroke. The mRS is a 6 point disability scale with possible scores ranging from 0 to 5. Higher score indicates worse outcome.
Time frame: 12 months from the stroke
Benefit of the job accommodations
Perceived benefit of the carried out job accommodations. Single item question with 5 point Likert scale (5=very much; 1=very little). Higher value indicates better outcome.
Time frame: 6 and 12 months
Job burnout symptoms
Job burnout symptoms measured with Burnout Assessment Tool (BAT) 4-item version. Averaged sum score: range 1-5. Higher score indicates worse outcome.
Time frame: 6 and 12 months
Depression symptoms
Depression symptoms measured with Patient health Questionnaire 9 question version (PHQ-9). Total score range 0-27. Higher score indicates worse outcome.
Time frame: 6 and 12 months
General life satisfaction
Perceived general life satisfaction measured with single item question with 5 point Likert scale (5=very satisfied; 1=very dissatisfied). Higher score indicates better outcome.
Time frame: 6 and 12 months
Daily function ability
Perceived daily ability to function measured with single item question (score range 0-10). Higher score indicates better outcome.
Time frame: 6 and 12 months
Amount of job accommodations
Amount of the actualized job accommodations measured with single item question. Ordinal 4 item scale. (3=A lot , 2=somewhat, 1=a little, 0=not at all). Higher value indicates better outcome.
Time frame: 6 and 12 months
Work participation
Monthly work participation percentage (%) as compared to fulltime working. Higher value indicate better outcome.
Time frame: 6 and 12 months
Cognitive test performance
Performance in web-based cognitive tests measuring reaction time, attention, executive functions and verbal memory functions. Applied cognitive tests are Task Switching test and Verbal memory test (modified version of the RAVLT).
Time frame: 6 and 12 months
Level of social support
Self-reported level of social support measured with Oslo Social Support Scale 3-item version (OSSS-3). Sum score range 3-14. Higher score represent better outcome.
Time frame: 6 and 12 months
Plan to share: No — IPD not shared
No publications or documents are linked to this record.
Started Jan 2025 (actual). Primary completion is estimated for Dec 2026, 23 months after the start.
Of 576 non-industry interventional studies with no phase under Ischemic Stroke, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 48. This study's planned 23 months is below that.
Counting every sponsor, half of 656 studies reached it within 27 months; a quarter within 14 and three quarters within 48.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Finnish Institute of Occupational Health